Estimated $43.0M - $43.5M in Rubraca® (rucaparib) global sales for Q4 2020 and $164.2M - $164.7M for FY 2020
Q4/FY 2020 Operating Results call planned for February 23, 2021
Company to present at J.P. Morgan Healthcare Conference on Tuesday, January 12
A live webcast of the presentation/Q&A session can be accessed through the investor relations section of the Company’s website at clovisoncology.com. Approximately 24 hours following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.